Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-11-03

FDA Approved: CAPTOPRIL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved Hikma Pharmaceuticals USA's supplemental application for captopril (CAPTOPRIL), enabling the generic captopril product under the approved ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CAPTOPRIL (Captopril)

Snippet

SUPPL AP for CAPTOPRIL (CAPTOPRIL)